MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 93 filers reported holding MYOVANT SCIENCES LTD in Q2 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $15,505,100 | -10.9% | 575,115 | -40.6% | 0.00% | -20.0% |
| Q3 2022 | $17,403,000 | +41.7% | 968,965 | -1.9% | 0.01% | +66.7% |
| Q2 2022 | $12,281,000 | -16.4% | 987,930 | -10.5% | 0.00% | +50.0% |
| Q1 2022 | $14,695,000 | -65.4% | 1,103,284 | -59.5% | 0.00% | 0.0% |
| Q4 2021 | $42,458,000 | +74.7% | 2,726,988 | +151.8% | 0.00% | -33.3% |
| Q3 2021 | $24,301,000 | -25.2% | 1,082,945 | -24.1% | 0.00% | -40.0% |
| Q2 2021 | $32,485,000 | +15.3% | 1,426,667 | +4.2% | 0.01% | +25.0% |
| Q1 2021 | $28,186,000 | -40.8% | 1,369,582 | -20.6% | 0.00% | +33.3% |
| Q4 2020 | $47,636,000 | +308.3% | 1,724,708 | +107.7% | 0.00% | +50.0% |
| Q3 2020 | $11,666,000 | +0.9% | 830,365 | +48.2% | 0.00% | -33.3% |
| Q2 2020 | $11,557,000 | +1062.7% | 560,489 | +325.7% | 0.00% | – |
| Q1 2020 | $994,000 | -71.8% | 131,662 | -42.1% | 0.00% | -100.0% |
| Q4 2019 | $3,526,000 | +444.1% | 227,200 | +309.9% | 0.00% | – |
| Q2 2017 | $648,000 | – | 55,426 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 85,000 | $1,132,000 | 1.20% |
| Bellevue Group AG | 5,859,039 | $78,042,000 | 0.91% |
| APIS CAPITAL ADVISORS, LLC | 40,000 | $533,000 | 0.64% |
| Pier Capital, LLC | 294,954 | $3,929,000 | 0.50% |
| Resolute Capital Asset Partners LLC | 50,000 | $666,000 | 0.42% |
| Rhenman & Partners Asset Management AB | 249,300 | $3,321,000 | 0.33% |
| Hennion & Walsh Asset Management, Inc. | 409,079 | $5,449,000 | 0.29% |
| TORRAY INVESTMENT PARTNERS LLC | 79,868 | $1,064,000 | 0.17% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 195,211 | $2,600,000 | 0.08% |
| DUALITY ADVISERS, LP | 54,164 | $721,000 | 0.08% |